Other Metabolic Benefits In the T2D trial, there were also dose-response reductions in HbA1c: retatrutide 12 mg reduced HbA1c by 2.16% at 36 weeks, corresponding to an estimated difference from dulaglutide 1.5 mg of -0.80% (95% CI: -1.16, -0.44)
You'll usually see concentrations between 0.1-0.5% in formulations
Clinically, Gluthasil C Nano Shots are ideal for individuals seeking antioxidant support, skin brightening, or overall wellness enhancement
Lipoic Acid (R-Fraction) : Antioxidant compound included to support oxidative stress balance
A multicenter, sham-controlled randomized trial included 127 BE patients with low-grade dysplasia (LGD) or HGD
The REMAIN-1 Pivotal Cohort has completed enrollment, and the Company remains on track to randomize patients in early 2026 and deliver 6-month topline primary endpoint data and potentially file a PMA in H2 2026